Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb;25(2):235-237.
doi: 10.1002/ejhf.2766. Epub 2023 Jan 16.

Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure

Stephan von Haehling  1   2 , Ryosuke Sato  1 , Javed Butler  3   4 , Stefan D Anker  5   6
Affiliations
Free article
Editorial

Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure

Stephan von Haehling et al. Eur J Heart Fail. 2023 Feb.
Free article
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Seferović PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, et al. Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure. Eur J Heart Fail. 2020;22:1984-6.
    1. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al.; EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383:1413-24.
    1. McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al.; DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995-2008.
    1. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al.; EMPEROR-Preserved Trial Investigators. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451-61.
    1. Solomon SD, JJV MM, Claggett B, de Boer RA, de Mets D, Hernandez AF, et al.; DELIVER Trial Committees and Investigators. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387:1089-98.

LinkOut - more resources